EXPERT
Susan E. Harley
Pathologist
Dr. Susan Harley is a pathologist practicing in Mobile, AL. Dr. Harley is a doctor who specializes in the study of bodily fluids and tissues. As a pathologist, Dr. Harley can help your primary care doctor make a diagnosis about your medical condition. Dr. Harley may perform a tissue biopsy to determine if a patient has cancer, practice genetic testing, and complete a number of laboratory examinations. Pathologists can also perform autopsies which can determine a persons cause of death and gain information about genetic progression of a disease.
22 years
Experience
Susan E. Harley
- Mobile, AL
- Universtiy of Minnesota
- Accepting new patients
No results found
Is pathology of pleomorphic adenoma accurate?
Fine needle aspiration cytology (FNAC) is a generally reliable, minimally invasive diagnostic method with a high sensitivity in diagnosis of lesions in parotid glands. It does READ MORE
Fine needle aspiration cytology (FNAC) is a generally reliable, minimally invasive diagnostic method with a high sensitivity in diagnosis of lesions in parotid glands. It does provide excellent distinction between benign and malignant parotid tumors.
Evidence of reliability of FNAs for parotid lesions is as follows:
There was a retrospective study performed in 2016 that looked at over 100 cases of parotid tumors that had been diagnosed over the past 10 years. Over 90 of them were initially evaluated by FNA; this study compared their initial FNA diagnosis to the final diagnosis made after the tumor was surgically removed. Pleomorphic adenoma (PA) was the most common neoplasm identified (found in 63% of cases), followed by other benign neoplasms and, less commonly, malignancies. The overall accuracy of FNAC for parotid masses was estimated to be 95%.
“False-negative diagnoses were found in mucoepidermoid carcinoma (n=1; 1.4%), acinic cell carcinoma (n=1; 1.4%), and epithelial-myoepithelial carcinoma (n=1; 1.4%) whereas there were false-positive diagnoses in cases of pleomorphic adenoma (n=2; 2.7%) and in normal parotid tissue (n=1; 1.4%).” (Gudmundsson et al.)*
In this case, “negative” is a shortened version of “negative for malignancy,” meaning benign; “positive” is short for “positive for malignancy.” A false negative means that the case was (on FNA) initially diagnosed as benign, but on final pathology was malignant (so in the above paragraph, for all the cases where the final pathology was mucoepidermoid carcinoma, 1 case was initially diagnosed falsely as “negative for malignancy” or benign, but when resected turned out to be a mucoepidermoid cancer, which is a malignant tumor). A false positive means that the case was initially diagnosed as malignant (with FNA), but on final pathology was found to be benign. The tumors found to be pleomorphic adenomas did have 2 cases falsely identified as malignant on FNA which on resection were found to be benign; no cases in this study that were diagnosed by FNA as benign were found to be malignant.
Based on the above study, the evidence shows that FNAs are excellent at diagnosing parotid tumors, including PAs, and that their findings of “benign” versus “malignant” are overall very reliable.
Thank you for your question. Please let me know if I can assist you or answer other questions in the future.
Best,
Dr. Harley
Evidence of reliability of FNAs for parotid lesions is as follows:
There was a retrospective study performed in 2016 that looked at over 100 cases of parotid tumors that had been diagnosed over the past 10 years. Over 90 of them were initially evaluated by FNA; this study compared their initial FNA diagnosis to the final diagnosis made after the tumor was surgically removed. Pleomorphic adenoma (PA) was the most common neoplasm identified (found in 63% of cases), followed by other benign neoplasms and, less commonly, malignancies. The overall accuracy of FNAC for parotid masses was estimated to be 95%.
“False-negative diagnoses were found in mucoepidermoid carcinoma (n=1; 1.4%), acinic cell carcinoma (n=1; 1.4%), and epithelial-myoepithelial carcinoma (n=1; 1.4%) whereas there were false-positive diagnoses in cases of pleomorphic adenoma (n=2; 2.7%) and in normal parotid tissue (n=1; 1.4%).” (Gudmundsson et al.)*
In this case, “negative” is a shortened version of “negative for malignancy,” meaning benign; “positive” is short for “positive for malignancy.” A false negative means that the case was (on FNA) initially diagnosed as benign, but on final pathology was malignant (so in the above paragraph, for all the cases where the final pathology was mucoepidermoid carcinoma, 1 case was initially diagnosed falsely as “negative for malignancy” or benign, but when resected turned out to be a mucoepidermoid cancer, which is a malignant tumor). A false positive means that the case was initially diagnosed as malignant (with FNA), but on final pathology was found to be benign. The tumors found to be pleomorphic adenomas did have 2 cases falsely identified as malignant on FNA which on resection were found to be benign; no cases in this study that were diagnosed by FNA as benign were found to be malignant.
Based on the above study, the evidence shows that FNAs are excellent at diagnosing parotid tumors, including PAs, and that their findings of “benign” versus “malignant” are overall very reliable.
Thank you for your question. Please let me know if I can assist you or answer other questions in the future.
Best,
Dr. Harley
